Kaplan–Meier analysis showed ccRCC patients with higher COL18A1-AS1 expression had a better overall survival (OS) (Fig. 1C, Supplementary Fig. 2) and disease-free survival (DFS) (Fig. 1D, Supplementary Fig. 3). This evidence concerns the gene COL18A1 and nonpapillary renal cell carcinoma.